Praxis Precision Medicines (PRAX) Return on Sales (2023 - 2025)

Praxis Precision Medicines' Return on Sales history runs 3 years deep, the most recent figure standing at 0.7% for Q3 2025.

• In Q3 2025, Return on Sales rose 156.0% year-over-year to 0.7%; the TTM figure through Sep 2025 stood at 0.7% (up 162.0% YoY), while the FY2024 annual figure was 0.49%, up 76.0% from the prior year.
• Return on Sales for Q3 2025 stood at 0.7%, down from 0.65% in the prior quarter.
• The five-year high for Return on Sales was 0.38% in Q4 2024, with the low at 4.04% in Q4 2023.
• The 3-year median for Return on Sales is 0.65% (2025), against an average of 1.14%.
• Peak annual rise in Return on Sales reached 367 bps in 2024, while the deepest fall reached 171 bps in 2024.
• Praxis Precision Medicines' Return on Sales stood at 4.04% in 2023, then surged by 91 bps to 0.38% in 2024, then slumped by 85 bps to 0.7% in 2025.
• Business Quant data shows PRAX's Return on Sales at 0.7% in Q3 2025, 0.65% in Q2 2025, and 0.57% in Q1 2025.